Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only,...
FDA Drug Recall #D-0014-2025 — Class II — September 25, 2024
Recall Summary
| Recall Number | D-0014-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 25, 2024 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Kabi Compounding, LLC |
| Location | Canton, MA |
| Product Type | Drugs |
| Quantity | 1313 bags |
Product Description
Phenylephrine HCl 0.9% Sodium Chloride Injection USP, 20 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-002-58
Reason for Recall
CGMP violations
Distribution Pattern
Product was distributed to 125 direct accounts nationwide.
Lot / Code Information
Lot# C274-000039006, exp. date 19-Jan-25
Other Recalls from Fresenius Kabi Compounding, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0336-2026 | Class II | vancomycin HCl, 1.5 grams, 1.5 grams added to 5... | Feb 5, 2026 |
| D-0333-2026 | Class II | acyclovir sodium, 200 mg, 200mg added to 100 mL... | Feb 5, 2026 |
| D-0337-2026 | Class II | vancomycin HCl, 2 grams, 2 grams added to 500 m... | Feb 5, 2026 |
| D-0334-2026 | Class II | ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10... | Feb 5, 2026 |
| D-0335-2026 | Class II | thiamine HCl, 500 mg, 500 mg added to 100 mL, 0... | Feb 5, 2026 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.